Moody Lynn & Lieberson’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.6M Sell
15,426
-405
-3% -$69.3K 0.15% 74
2025
Q4
$2.67M Buy
15,831
+10,426
+193% +$1.69M 0.14% 74
2025
Q3
$780K Hold
5,405
0.04% 136
2025
Q2
$684K Hold
5,405
0.04% 153
2025
Q1
$691K Hold
5,405
0.04% 143
2024
Q4
$715K Sell
5,405
-1,600
-23% -$225K 0.04% 141
2024
Q3
$1.02M Hold
7,005
0.06% 130
2024
Q2
$962K Sell
7,005
-600
-8% -$80.1K 0.06% 121
2024
Q1
$1.04M Sell
7,605
-300
-4% -$41K 0.07% 115
2023
Q4
$1.07M Sell
7,905
-1,100
-12% -$134K 0.08% 114
2023
Q3
$1.1M Sell
9,005
-2,500
-22% -$318K 0.09% 101
2023
Q2
$1.46M Hold
11,505
0.12% 89
2023
Q1
$1.49M Hold
11,505
0.13% 91
2022
Q4
$1.51M Hold
11,505
0.14% 93
2022
Q3
$1.35M Sell
11,505
-165
-1% -$20.5K 0.13% 93
2022
Q2
$1.37M Sell
11,670
-13,850
-54% -$1.64M 0.12% 96
2022
Q1
$3.33M Buy
25,520
+14,695
+136% +$1.91M 0.24% 74
2021
Q4
$1.65M Hold
10,825
0.11% 98
2021
Q3
$1.75M Hold
10,825
0.13% 92
2021
Q2
$1.77M Hold
10,825
0.13% 90
2021
Q1
$1.63M Hold
10,825
0.14% 91
2020
Q4
$1.64M Hold
10,825
0.14% 90
2020
Q3
$1.47M Hold
10,825
0.15% 86
2020
Q2
$1.48M Hold
10,825
0.16% 82
2020
Q1
$1.17K Hold
10,825
0.16% 73
2019
Q4
$1.3M Hold
10,825
0.13% 105
2019
Q3
$1.08M Hold
10,825
0.12% 93
2019
Q2
$1.18M Hold
10,825
0.13% 95
2019
Q1
$1.21M Hold
10,825
0.14% 90
2018
Q4
$1.04M Hold
10,825
0.14% 92
2018
Q3
$1.32M Hold
10,825
0.14% 95
2018
Q2
$1.19M Sell
10,825
-160
-1% -$17.1K 0.14% 98
2018
Q1
$1.17M Sell
10,985
-700
-6% -$77.6K 0.14% 95
2017
Q4
$1.36M Sell
11,685
-21
-0.2% -$2.25K 0.15% 93
2017
Q3
$1.3M Buy
11,706
+21
+0.2% +$2.24K 0.16% 96
2017
Q2
$1.21M Buy
11,685
+6,855
+142% +$675K 0.16% 90
2017
Q1
$472K Hold
4,830
0.07% 125
2016
Q4
$427K Buy
+4,830
New +$440K 0.06% 130

Other funds holding IBB